CareDx Company Profile (NASDAQ:CDNA)

About CareDx (NASDAQ:CDNA)

CareDx logoCareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection. Its products under development for transplant monitoring include AlloSure, a development-stage transplant surveillance solution, which applies next generation sequencing to detect and quantitate genetic differences between donor-derived cell-free deoxyribonucleic acid (dd-cfDNA) in the blood stream emanating from the donor heart. It offers the AlloMap Score Variability service, which provides complementary information to help personalize long-term care of heart transplant recipients.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Research Services
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CDNA
  • CUSIP: N/A
  • Web:
  • Market Cap: $21.82 million
  • Outstanding Shares: 21,391,000
Average Prices:
  • 50 Day Moving Avg: $1.02
  • 200 Day Moving Avg: $2.17
  • 52 Week Range: $0.76 - $6.08
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.37
  • P/E Growth: -0.07
Sales & Book Value:
  • Annual Revenue: $40.63 million
  • Price / Sales: 0.54
  • Book Value: $0.92 per share
  • Price / Book: 1.11
  • EBIDTA: ($12,880,000.00)
  • Net Margins: -78.62%
  • Return on Equity: -57.94%
  • Return on Assets: -22.51%
  • Debt-to-Equity Ratio: 0.23%
  • Current Ratio: 0.89%
  • Quick Ratio: 0.70%
  • Average Volume: 163,725 shs.
  • Beta: 0.73
  • Short Ratio: 6.71

Frequently Asked Questions for CareDx (NASDAQ:CDNA)

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

How were CareDx's earnings last quarter?

CareDx Inc (NASDAQ:CDNA) released its earnings results on Wednesday, August, 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.28) by $0.01. The firm had revenue of $10.70 million for the quarter, compared to the consensus estimate of $10.42 million. CareDx had a negative return on equity of 57.94% and a negative net margin of 78.62%. CareDx's revenue for the quarter was up 50.7% on a year-over-year basis. During the same quarter last year, the company posted ($0.27) EPS. View CareDx's Earnings History.

What guidance has CareDx issued on next quarter's earnings?

CareDx issued an update on its first quarter earnings guidance on Monday, May, 22nd. The company provided earnings per share (EPS) guidance of ($0.32-0.27) for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($0.19). The company issued revenue guidance of $11.4-11.6 million, compared to the consensus revenue estimate of $11.22 million.

Where is CareDx's stock going? Where will CareDx's stock price be in 2017?

3 brokers have issued 1 year target prices for CareDx's stock. Their predictions range from $6.00 to $12.00. On average, they anticipate CareDx's share price to reach $9.00 in the next year. View Analyst Ratings for CareDx.

Are investors shorting CareDx?

CareDx saw a decrease in short interest in the month of April. As of April 28th, there was short interest totalling 52,210 shares, a decrease of 72.0% from the April 13th total of 186,345 shares. Based on an average daily trading volume, of 109,359 shares, the days-to-cover ratio is presently 0.5 days.

Who are some of CareDx's key competitors?

Who owns CareDx stock?

CareDx's stock is owned by many different of institutional and retail investors. Top institutional investors include Gagnon Securities LLC (9.47%), Gagnon Advisors LLC (4.45%), Royce & Associates LP (2.46%), Vanguard Group Inc. (1.35%), California Public Employees Retirement System (0.82%) and TPG Group Holdings SBS Advisors Inc. (0.82%). Company insiders that own CareDx stock include Neil Gagnon and Peter Maag. View Institutional Ownership Trends for CareDx.

Who bought CareDx stock? Who is buying CareDx stock?

CareDx's stock was purchased by a variety of institutional investors in the last quarter, including Gagnon Securities LLC, Royce & Associates LP and Armstrong Henry H Associates Inc.. Company insiders that have bought CareDx stock in the last two years include Neil Gagnon and Peter Maag. View Insider Buying and Selling for CareDx.

How do I buy CareDx stock?

Shares of CareDx can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of CareDx stock cost?

One share of CareDx stock can currently be purchased for approximately $1.02.

Analyst Ratings

Consensus Ratings for CareDx (NASDAQ:CDNA) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.00 (782.35% upside)

Analysts' Ratings History for CareDx (NASDAQ:CDNA)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$6.00N/AView Rating Details
6/14/2016Leerink SwannReiterated RatingBuyN/AView Rating Details
6/14/2016MizuhoBoost Price TargetBuy$8.00 -> $12.00N/AView Rating Details
2/9/2016Janney Montgomery ScottInitiated CoverageBuy -> Buy$12.00N/AView Rating Details
11/18/2015Craig HallumBoost Price TargetBuy$10.00 -> $13.00N/AView Rating Details
9/28/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 5/28/2015 forward)


Earnings History for CareDx (NASDAQ:CDNA)
Earnings by Quarter for CareDx (NASDAQ:CDNA)
Earnings History by Quarter for CareDx (NASDAQ:CDNA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016Q3 2016($0.25)($0.17)$11.50 million$12.48 millionViewListenView Earnings Details
8/10/2016Q216($0.28)($0.29)$10.42 million$10.70 millionViewListenView Earnings Details
5/6/2016Q1($0.31)($0.37)$6.97 million$6.60 millionViewN/AView Earnings Details
3/24/2016Q415($0.34)($0.40)$7.44 million$6.60 millionViewListenView Earnings Details
11/11/2015Q315($0.25)($0.29)$7.34 million$7.15 millionViewListenView Earnings Details
8/10/2015Q215($0.18)($0.27)$7.28 million$7.13 millionViewListenView Earnings Details
5/12/2015Q115($0.17)($0.19)$6.82 million$7.22 millionViewListenView Earnings Details
11/10/2014Q314($0.13)$0.01$6.60 million$6.65 millionViewN/AView Earnings Details
8/27/2014Q2 14($0.13)($0.09)$6.18 million$6.78 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CareDx (NASDAQ:CDNA)
Current Year EPS Consensus Estimate: $-0.69 EPS
Next Year EPS Consensus Estimate: $-0.43 EPS


Dividend History for CareDx (NASDAQ:CDNA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for CareDx (NASDAQ:CDNA)
Insider Ownership Percentage: 13.33%
Institutional Ownership Percentage: 38.35%
Insider Trades by Quarter for CareDx (NASDAQ:CDNA)
Institutional Ownership by Quarter for CareDx (NASDAQ:CDNA)
Insider Trades by Quarter for CareDx (NASDAQ:CDNA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2017Neil GagnonMajor ShareholderBuy7,439$1.00$7,439.00View SEC Filing  
5/23/2017Neil GagnonMajor ShareholderBuy6,836$1.04$7,109.44View SEC Filing  
4/28/2017Neil GagnonMajor ShareholderBuy15,116$0.89$13,453.24View SEC Filing  
3/16/2017Neil GagnonMajor ShareholderBuy123,160$1.83$225,382.80View SEC Filing  
9/22/2016Neil GagnonMajor ShareholderBuy178,686$4.00$714,744.00View SEC Filing  
4/14/2016Neil GagnonMajor ShareholderBuy93,240$4.02$374,824.80View SEC Filing  
10/21/2015Neil Gagnonmajor shareholderBuy1,431$4.99$7,140.69View SEC Filing  
10/20/2015Neil GagnonMajor ShareholderBuy1,347$4.92$6,627.24View SEC Filing  
9/29/2015Neil Gagnonmajor shareholderBuy6,332$6.10$38,625.20View SEC Filing  
9/4/2015Neil GagnonMajor ShareholderBuy69,383$6.95$482,211.85View SEC Filing  
6/5/2015Neil GagnonMajor ShareholderBuy6,500$5.69$36,985.00View SEC Filing  
6/1/2015Peter MaagCEOBuy2,000$4.84$9,680.00View SEC Filing  
4/17/2015Neil GagnonMajor ShareholderBuy13,051$5.34$69,692.34View SEC Filing  
3/20/2015Neil GagnonMajor ShareholderBuy6,324$6.35$40,157.40View SEC Filing  
2/27/2015Neil GagnonMajor ShareholderBuy4,270$6.03$25,748.10View SEC Filing  
2/6/2015Neil GagnonMajor ShareholderBuy4,586$7.20$33,019.20View SEC Filing  
2/5/2015Neil GagnonMajor ShareholderBuy121,587$7.10$863,267.70View SEC Filing  
2/4/2015Neil GagnonMajor ShareholderBuy31,991$7.00$223,937.00View SEC Filing  
2/3/2015Neil GagnonMajor ShareholderBuy23,558$7.03$165,612.74View SEC Filing  
2/2/2015Neil GagnonMajor ShareholderBuy3,620$7.05$25,521.00View SEC Filing  
1/29/2015Neil GagnonMajor ShareholderBuy15,395$7.04$108,380.80View SEC Filing  
1/27/2015Neil GagnonMajor ShareholderBuy84,720$7.00$593,040.00View SEC Filing  
1/22/2015Neil GagnonMajor ShareholderBuy48,670$7.13$347,017.10View SEC Filing  
1/20/2015Neil GagnonMajor ShareholderBuy16,192$6.66$107,838.72View SEC Filing  
1/15/2015Neil GagnonMajor ShareholderBuy39,109$6.43$251,470.87View SEC Filing  
1/14/2015Neil GagnonMajor ShareholderBuy122,319$7.07$864,795.33View SEC Filing  
7/22/2014Ken LudlumCFOBuy7,000$10.00$70,000.00View SEC Filing  
7/22/2014Michael GoldbergDirectorBuy25,000$10.00$250,000.00View SEC Filing  
7/22/2014Perkins Caufield & Bye KleinerMajor ShareholderBuy52,770$10.00$527,700.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for CareDx (NASDAQ:CDNA)
Latest Headlines for CareDx (NASDAQ:CDNA)
DateHeadline logoCareDx Inc (CDNA) Upgraded at Zacks Investment Research - May 25 at 7:58 PM logoCareDx (CDNA) Receives Letter from Nasdaq Regarding Non-Compliance with Listing Rule - May 24 at 9:07 PM logoEdited Transcript of CDNA earnings conference call or presentation 22-May-17 8:30pm GMT - May 23 at 4:13 PM logoCareDx Inc (CDNA) Updates Q1 Earnings Guidance - May 22 at 5:10 PM logoCareDx Reports Preliminary First Quarter 2017 Financial Results - May 22 at 4:07 PM logoCareDx to Announce First Quarter 2017 Preliminary Financial Results on May 22, 2017 - May 19 at 8:52 AM logoZacks Investment Research Upgrades CareDx Inc (CDNA) to "Hold" - May 16 at 6:26 PM logoShort Interest in CareDx Inc (CDNA) Drops By 72.0% - May 14 at 9:14 AM logoZacks: Analysts Expect CareDx Inc (CDNA) Will Post Quarterly Sales of $11.01 Million - May 6 at 7:38 AM logo-$0.22 EPS Expected for CareDx Inc (CDNA) This Quarter - May 4 at 11:40 PM logoCareDx Achieves Significant Milestone Towards CMS Coverage for AlloSure - May 4 at 4:20 PM logoCareDx Inc (CDNA) Major Shareholder Neil Gagnon Buys 15,116 Shares - May 4 at 12:36 AM logoCareDx (CDNA) Receives Daily News Sentiment Score of 0.12 - May 3 at 11:52 PM logoInsider Buying: CareDx Inc (CDNA) Major Shareholder Buys 15,116 Shares of Stock - May 2 at 10:54 PM logoETFs with exposure to CareDx, Inc. : April 28, 2017 - April 28 at 5:10 PM logoCareDx to Present Key AlloSure Validation Data at ATC - April 28 at 5:10 PM logoCareDx (CDNA) Earning Favorable News Coverage, Study Shows - April 27 at 7:22 PM logoCareDx, Inc. :CDNA-US: Earnings Analysis: Q4, 2016 By the Numbers : April 27, 2017 - April 27 at 4:38 PM logoCareDx Inc (CDNA) Downgraded to "Sell" at Zacks Investment Research - April 24 at 6:10 PM logoCareDx (CDNA) Earning Positive Media Coverage, Report Shows - April 23 at 2:57 PM logoCareDx (CDNA) Names Michael Bell as New CFO - April 22 at 4:06 PM logoCareDx Reports Fourth Quarter and Full Year 2016 Financial Results - April 21 at 9:18 PM logoCareDx Announces Receipt of Expected Letter from Nasdaq - April 21 at 9:18 PM logoCareDx Appoints Michael Bell as Chief Financial Officer - April 21 at 9:18 PM logoCareDx reports 4Q loss - April 21 at 9:18 PM logoCareDx (CDNA) Receiving Somewhat Positive Media Coverage, AlphaOne Reports - April 20 at 4:08 PM logoCareDx (CDNA) Getting Somewhat Negative Press Coverage, Report Shows - April 17 at 2:14 PM logoCareDx Inc (CDNA) Expected to Post Quarterly Sales of $11.01 Million - April 15 at 7:58 AM logoCareDx to Present New Data on AlloMap and AlloSure at ISHLT - April 3 at 4:36 PM logoCan FactSet Research (FDS) Pull a Surprise in Q2 Earnings? - March 24 at 4:30 PM logoCareDx Inc (CDNA) Major Shareholder Purchases $225,382.80 in Stock - March 20 at 4:31 PM logoMid-Afternoon Market Update: Oracle Gains On Earnings Beat; TrovaGene Shares Slide - March 16 at 5:33 PM logoCareDx Closes New $25 Million Debt Facility - March 15 at 4:32 PM logoCareDx Reports Preliminary Fourth Quarter and FY 2016 Financial Results - March 15 at 4:32 PM logoCAREDX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agr - March 15 at 4:32 PM logoAlloSure Featured in Journal of Applied Laboratory Medicine - March 14 at 4:06 PM logoAlloSure Featured in Journal of the American Society of Nephrology - March 9 at 4:48 PM logo4:02 pm CareDx indicated higher after issuing press release highlighting agreement with Illumina (ILMN) for the acquisition of Conexio SBT Resolver products and Assign SBT analysis software for high resol - January 25 at 2:49 AM logoCareDx (CDNA) Signs Agreement to Acquire SBT Resolver HLA Typing Products from Illumina - January 24 at 4:47 PM logoCareDx to acquire SBT Resolver™ HLA Typing Products from Illumina - January 24 at 4:47 PM logoCAREDX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat - January 23 at 4:31 PM logoCAREDX, INC. Files SEC form 8-K, Regulation FD Disclosure - December 23 at 9:27 PM logoCMS Announces CLFS for 2017 – CareDx’s AlloMap Reimbursement Updated; Rate to Remain at $2,821 - November 21 at 10:08 PM logoAlloSure Detects Active Rejection in Kidney Transplant Patients - November 18 at 8:27 PM logoCAREDX, INC. Files SEC form 10-Q, Quarterly Report - November 15 at 10:43 AM logoEdited Transcript of CDNA earnings conference call or presentation 9-Nov-16 9:30pm GMT - November 10 at 10:07 PM logoQ3 2016 CareDx Inc Earnings Release - After Market Close - November 9 at 1:07 PM logoCareDx to Participate in Upcoming Investor Conferences - November 8 at 9:39 PM logoCareDx to present AlloSure® data at AMP in Charlotte, NC - November 3 at 9:09 PM logoCareDx to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 9, 201 - October 27 at 9:41 PM



CareDx (CDNA) Chart for Sunday, May, 28, 2017

This page was last updated on 5/28/2017 by Staff